Related Experiment Video
Updated: Jul 3, 2026
Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind,
Rolf J Postema1, Charlotte M Kingma, Hero P Wit
1Department of Otorhinolaryngology, University Medical Center Groningen, Groningen, The Netherlands.
Conclusions:
Intratympanic application of gentamicin is a relatively safe and efficient treatment for the reduction of complaints of vertigo attacks associated with Menière's disease. The treatment also reduces the severity of the perceived aural fullness.
Objective:
To investigate the effectiveness of intratympanic gentamicin treatment in patients with unilateral Menière's disease.
Subjects And Methods:
In a prospective, double-blind, randomized, placebo-controlled clinical trial subjects scored vertigo complaints, aural fullness and tinnitus, before, during and up to 1 year after treatment. Hearing loss was monitored with pure tone audiometry.
Results:
Gentamicin treatment resulted in a significant reduction of the score for vertigo complaints and the score for perceived aural fullness. A small increase in hearing loss (average 8 dB) was measured in the gentamicin group.
More Related Videos
06:55A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)
Published on: February 27, 2018
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
